Americann Inc (ACAN) 1.1400 $ACAN
AmeriCann Commences $2.5 Million Loan to Preferred Partner in Massachusetts
ACCESSWIRE - Thu Jun 02, 7:30AM CDT
Coastal Compassion has Started Construction on Its Registered Medical Dispensary in Fairhaven, MA
AmeriCann Board Approves Plan to Convert to First Medical Cannabis REIT
ACCESSWIRE - Fri Apr 29, 7:00AM CDT
Developer Plans Real Estate Investment Trust (REIT) Status to Accelerate National Expansion
New Magazine Focused on Informing Cannabis Investors Launches Its Premier Issue
ACCESSWIRE - Thu Apr 21, 9:02AM CDT
ATLANTA, GA / ACCESSWIRE / April 21, 2016 / CANNAINVESTOR Magazine, is pleased to announce the inaugural launch of its new magazine on Thursday, April 21, 2016. We invite all cannabis investors, analysts, entrepreneurs, and the financial media to subscribe at www.cannainvestormag.com. The April/May magazine issue will be the first issue of a monthly series and will be available in digital and print forms. The digital version of the magazine will be complimentary and can be viewed by visiting www.cannainvestormag.com.
AmeriCann Continues National Expansion with Delaware Medical Cannabis Partnership
ACCESSWIRE - Thu Apr 21, 7:00AM CDT
Definitive Agreement to Develop Delaware Medical Cannabis Center 200,000 Square Foot Greenhouse Facility in Dover
AmeriCann Secures First Tenant for its Massachusetts Medical Cannabis Center
ACCESSWIRE - Thu Apr 14, 7:01AM CDT
Definitive Agreement with Medical Marijuana Licensee for up to 600,000 Square Feet of the Approved 1 Million Square Foot Facility
Mentor Capital Cannabis Index Gains During Election Cycle
BusinessWire - Mon Mar 21, 6:47AM CDT
Mentor Capital, Inc. (OTCQB:MNTR) announced that Mentor's Cannabis Index for Value Investors has gained 22% YTD during 2016. According to Mentor CEO, Chet Billingsley, "The index was boosted by GW Pharmaceuticals' (NASDAQ:GWPH) recent doubling after its cannabidiol drug for childhood epilepsy received a positive nod from the FDA." The other leaders reported by Mentor in its marijuana index were indoor cultivation system experts Surna, Inc., (OTCQB:SRNA) at (326%) and new cannabis patent participant Mentor Capital at (354%), when compared to NASDAQ average unit sales, book value and growth set together at (100%).
GWPH: 93.47 (+0.54)
Mentor Capital Releases 2016 Cannabis Value Index
BusinessWire - Wed Jan 20, 6:30AM CST
Mentor Capital, Inc. (OTCQB:MNTR) announces that Mentor's 2016 Cannabis Index for Value Investors is led by Digipath, Inc. (OTCQB
IGP) at (621%); Mentor Capital at (460%), and Cannavest Corp. (OTCQB:CANV) at (333%) when compared to NASDAQ average unit sales, book value and growth set together at (100%).
GWPH: 93.47 (+0.54)
AmeriCann Expands Advisory Board to Assist with Aggressive National Growth and Development Plans
ACCESSWIRE - Wed Aug 19, 7:31AM CDT
Two Significant New Appointments in Horticulture and Compliance Advance Company Capabilities
AmeriCann Reports Positive Results from its Partnership with a Colorado Cannabis Producer
ACCESSWIRE - Thu Aug 06, 7:30AM CDT
Company's Preferred Partner Achieves Success Additional Opportunities in Colorado, Illinois and Massachusetts
AmeriCann Adds Two Accomplished Members to Its Advisory Board to Assist the Company with National Growth
ACCESSWIRE - Wed Jul 29, 7:30AM CDT
Appointments Enhance Expertise as the Company Launches New Research Programs
AmeriCann to Present at Cannabis Investor Webcast on Thursday, July 16, 2015
ACCESSWIRE - Wed Jul 15, 7:30AM CDT
Scheduled for 12pm EDT; CEO Tim Keogh to Discuss Business Model and Strategic Vision
AmeriCann to Develop Medical Cannabis Production Center with Approved Illinois Licensee
Filing Services Canada - Wed Mar 11, 7:32AM CDT
AmeriCann to Develop Medical Cannabis Production Center with Approved Illinois Licensee Facility Planned to Generate $125 Million in Annual Revenue Targeting Commercialization by Fall 2015 Denver, Colorado (FSCwire) - AmeriCann, Inc. (OTCQX Markets: ACAN), a company that designs, develops and owns advanced medical cannabis facilities, announced that it has expanded the scope of its partnership in Illinois. The Companys partner, Wellness Group Pharms (WGP), recently received one of the eighteen highly coveted medical cannabis cultivation and processing licenses from the State of Illinois. The amended agreement calls for AmeriCann to serve as the developer of a new facility to be called the Illinois Medical Cannabis Center (IMCC). WGP plans to utilize the IMCC facilities to cultivate, process and distribute medical cannabis to many of the states 52 newly licensed medical dispensaries. When fully constructed, the IMCC will contain approximately 285,000 square feet capable of producing an estimated 50,000 pounds annually of medical cannabis. The facility will be located in Anna, Illinois and is expected to provide over 175 full and part time jobs to Southern Illinois. AmeriCann will serve as the project developer and will own the IMCC, plus provide working capital funding and horticultural assistance to WGP. AmeriCann will receive a performance fee on all sales, a royalty on AmeriCanns infused product and extraction line, a monthly consulting fee and monthly lease payments. AmeriCann partnered with Wellness Group Pharms prior to the submittal of WGPs application in Illinois. Paul Montes, Managing Partner of WGP stated that, Our affiliation with AmeriCann was instrumental in our success in being awarded one of the few cultivation licenses granted in an extremely competitive Illinois application process. Only approximately 10% of those that applied for cultivation licenses were awarded licenses. Mr. Montes added, AmeriCann is delivering a level of expertise and resources that is unequaled in the industry. Our partnership is excellent because we share a commitment to provide the best medical marijuana possible to the patients in Illinois." AmeriCann intends to commence construction of the IMCC in March with a first phase of approximately 27,000 square feet. WPGs initial harvest is projected for late Fall 2015. AmeriCann plans to add additional cultivation capacity as the Illinois Medical Cannabis Program develops. AmeriCann provided initial project funding of $600,000 to WGP on February 23, 2015. AmeriCanns goal is to serve medical cannabis patients by providing state of the art facilities designed and built to produce high quality, consistent medicine that is cultivated and processed in a controlled, secure, and sustainable environment, said Tim Keogh, CEO of AmeriCann, Inc. With the inclusion of the IMCC project, the company has over one million square feet of greenhouse cultivation and processing facilities in the various planning stages and expects to build a significant portion of the planned facilities during 2015. With a population of over 12.7 million people, Illinois is the fifth largest state in the U.S. and one of the largest to adopt a medical marijuana program. AmeriCann plans to develop comparable facilities in other states that allow for the production and sale of medical cannabis to patients. On January 14, 2015 AmeriCann announced plans to acquire a 52.6-acre parcel of undeveloped land approximately 47 miles southeast of Boston and to develop the property as the Massachusetts Medical Cannabis Center. Previously AmeriCann closed on a $2,250,000 all cash purchase of a five-acre parcel of land in Denver, Colorado with plans to develop it as the Denver Medical Cannabis Center. Plans for this project include 125,000 square feet of greenhouse and other facilities. The project has received preliminary approval from the local planning board. AmeriCann has offices in Denver and Boston. The Company does not cultivate, process or sell cannabis. Contact Information Investors: Hayden IR hart@haydenir.com 917-658-7878 Media: media@ACANinfo.com (mailto:media@ACANinfo.com) 303-862-9000 To view this press release as a PDF file, click onto the following link: http://www.fscwire.com/sites/default/files/ne...2015_0.pdf Source: Americann Inc. (OTCQX:ACAN) http://acaninfo.com/ Maximum News Dissemination by FSCwire. http://www.fscwire.com Copyright(C)2015 Filing Services Canada Inc.
AmeriCann Engages Hayden IR To Develop Comprehensive Investor Relations Program
ACCESSWIRE - Mon Dec 08, 8:00AM CST
Focused on Increasing Awareness and Enhancing Shareholder Value
AmeriCann Partners with Medical Marijuana Applicants in Illinois in $9 Million Alliance
PR Newswire - Mon Oct 20, 5:00AM CDT
AmeriCann, Inc. (ACAN OTCQX), a company that develops cannabis cultivation facilities and provides capital for cannabis entrepreneurs, has partnered with local medical marijuana applicants in the state of Illinois.
AmeriCann, Inc. Commences Trading on the OTCQX Marketplace
PR Newswire - Tue Oct 14, 5:00AM CDT
AmeriCann, Inc. (OTCQX: ACAN), a company that develops cannabis cultivation facilities and provides capital for medical marijuana entrepreneurs, announced that it has been approved for and commenced trading on the OTCQX marketplace, effective October 8, 2014.
AmeriCann Commences $2.5 Million Loan to Preferred Partner in Massachusetts
ACCESSWIRE - Thu Jun 02, 7:30AM CDT
Coastal Compassion has Started Construction on Its Registered Medical Dispensary in Fairhaven, MA
AmeriCann Board Approves Plan to Convert to First Medical Cannabis REIT
ACCESSWIRE - Fri Apr 29, 7:00AM CDT
Developer Plans Real Estate Investment Trust (REIT) Status to Accelerate National Expansion
New Magazine Focused on Informing Cannabis Investors Launches Its Premier Issue
ACCESSWIRE - Thu Apr 21, 9:02AM CDT
ATLANTA, GA / ACCESSWIRE / April 21, 2016 / CANNAINVESTOR Magazine, is pleased to announce the inaugural launch of its new magazine on Thursday, April 21, 2016. We invite all cannabis investors, analysts, entrepreneurs, and the financial media to subscribe at www.cannainvestormag.com. The April/May magazine issue will be the first issue of a monthly series and will be available in digital and print forms. The digital version of the magazine will be complimentary and can be viewed by visiting www.cannainvestormag.com.
AmeriCann Continues National Expansion with Delaware Medical Cannabis Partnership
ACCESSWIRE - Thu Apr 21, 7:00AM CDT
Definitive Agreement to Develop Delaware Medical Cannabis Center 200,000 Square Foot Greenhouse Facility in Dover
AmeriCann Secures First Tenant for its Massachusetts Medical Cannabis Center
ACCESSWIRE - Thu Apr 14, 7:01AM CDT
Definitive Agreement with Medical Marijuana Licensee for up to 600,000 Square Feet of the Approved 1 Million Square Foot Facility
Mentor Capital Cannabis Index Gains During Election Cycle
BusinessWire - Mon Mar 21, 6:47AM CDT
Mentor Capital, Inc. (OTCQB:MNTR) announced that Mentor's Cannabis Index for Value Investors has gained 22% YTD during 2016. According to Mentor CEO, Chet Billingsley, "The index was boosted by GW Pharmaceuticals' (NASDAQ:GWPH) recent doubling after its cannabidiol drug for childhood epilepsy received a positive nod from the FDA." The other leaders reported by Mentor in its marijuana index were indoor cultivation system experts Surna, Inc., (OTCQB:SRNA) at (326%) and new cannabis patent participant Mentor Capital at (354%), when compared to NASDAQ average unit sales, book value and growth set together at (100%).
GWPH: 93.47 (+0.54)
Mentor Capital Releases 2016 Cannabis Value Index
BusinessWire - Wed Jan 20, 6:30AM CST
Mentor Capital, Inc. (OTCQB:MNTR) announces that Mentor's 2016 Cannabis Index for Value Investors is led by Digipath, Inc. (OTCQB
IGP) at (621%); Mentor Capital at (460%), and Cannavest Corp. (OTCQB:CANV) at (333%) when compared to NASDAQ average unit sales, book value and growth set together at (100%). GWPH: 93.47 (+0.54)
AmeriCann Expands Advisory Board to Assist with Aggressive National Growth and Development Plans
ACCESSWIRE - Wed Aug 19, 7:31AM CDT
Two Significant New Appointments in Horticulture and Compliance Advance Company Capabilities
AmeriCann Reports Positive Results from its Partnership with a Colorado Cannabis Producer
ACCESSWIRE - Thu Aug 06, 7:30AM CDT
Company's Preferred Partner Achieves Success Additional Opportunities in Colorado, Illinois and Massachusetts
AmeriCann Adds Two Accomplished Members to Its Advisory Board to Assist the Company with National Growth
ACCESSWIRE - Wed Jul 29, 7:30AM CDT
Appointments Enhance Expertise as the Company Launches New Research Programs
AmeriCann to Present at Cannabis Investor Webcast on Thursday, July 16, 2015
ACCESSWIRE - Wed Jul 15, 7:30AM CDT
Scheduled for 12pm EDT; CEO Tim Keogh to Discuss Business Model and Strategic Vision
AmeriCann to Develop Medical Cannabis Production Center with Approved Illinois Licensee
Filing Services Canada - Wed Mar 11, 7:32AM CDT
AmeriCann to Develop Medical Cannabis Production Center with Approved Illinois Licensee Facility Planned to Generate $125 Million in Annual Revenue Targeting Commercialization by Fall 2015 Denver, Colorado (FSCwire) - AmeriCann, Inc. (OTCQX Markets: ACAN), a company that designs, develops and owns advanced medical cannabis facilities, announced that it has expanded the scope of its partnership in Illinois. The Companys partner, Wellness Group Pharms (WGP), recently received one of the eighteen highly coveted medical cannabis cultivation and processing licenses from the State of Illinois. The amended agreement calls for AmeriCann to serve as the developer of a new facility to be called the Illinois Medical Cannabis Center (IMCC). WGP plans to utilize the IMCC facilities to cultivate, process and distribute medical cannabis to many of the states 52 newly licensed medical dispensaries. When fully constructed, the IMCC will contain approximately 285,000 square feet capable of producing an estimated 50,000 pounds annually of medical cannabis. The facility will be located in Anna, Illinois and is expected to provide over 175 full and part time jobs to Southern Illinois. AmeriCann will serve as the project developer and will own the IMCC, plus provide working capital funding and horticultural assistance to WGP. AmeriCann will receive a performance fee on all sales, a royalty on AmeriCanns infused product and extraction line, a monthly consulting fee and monthly lease payments. AmeriCann partnered with Wellness Group Pharms prior to the submittal of WGPs application in Illinois. Paul Montes, Managing Partner of WGP stated that, Our affiliation with AmeriCann was instrumental in our success in being awarded one of the few cultivation licenses granted in an extremely competitive Illinois application process. Only approximately 10% of those that applied for cultivation licenses were awarded licenses. Mr. Montes added, AmeriCann is delivering a level of expertise and resources that is unequaled in the industry. Our partnership is excellent because we share a commitment to provide the best medical marijuana possible to the patients in Illinois." AmeriCann intends to commence construction of the IMCC in March with a first phase of approximately 27,000 square feet. WPGs initial harvest is projected for late Fall 2015. AmeriCann plans to add additional cultivation capacity as the Illinois Medical Cannabis Program develops. AmeriCann provided initial project funding of $600,000 to WGP on February 23, 2015. AmeriCanns goal is to serve medical cannabis patients by providing state of the art facilities designed and built to produce high quality, consistent medicine that is cultivated and processed in a controlled, secure, and sustainable environment, said Tim Keogh, CEO of AmeriCann, Inc. With the inclusion of the IMCC project, the company has over one million square feet of greenhouse cultivation and processing facilities in the various planning stages and expects to build a significant portion of the planned facilities during 2015. With a population of over 12.7 million people, Illinois is the fifth largest state in the U.S. and one of the largest to adopt a medical marijuana program. AmeriCann plans to develop comparable facilities in other states that allow for the production and sale of medical cannabis to patients. On January 14, 2015 AmeriCann announced plans to acquire a 52.6-acre parcel of undeveloped land approximately 47 miles southeast of Boston and to develop the property as the Massachusetts Medical Cannabis Center. Previously AmeriCann closed on a $2,250,000 all cash purchase of a five-acre parcel of land in Denver, Colorado with plans to develop it as the Denver Medical Cannabis Center. Plans for this project include 125,000 square feet of greenhouse and other facilities. The project has received preliminary approval from the local planning board. AmeriCann has offices in Denver and Boston. The Company does not cultivate, process or sell cannabis. Contact Information Investors: Hayden IR hart@haydenir.com 917-658-7878 Media: media@ACANinfo.com (mailto:media@ACANinfo.com) 303-862-9000 To view this press release as a PDF file, click onto the following link: http://www.fscwire.com/sites/default/files/ne...2015_0.pdf Source: Americann Inc. (OTCQX:ACAN) http://acaninfo.com/ Maximum News Dissemination by FSCwire. http://www.fscwire.com Copyright(C)2015 Filing Services Canada Inc.
AmeriCann Engages Hayden IR To Develop Comprehensive Investor Relations Program
ACCESSWIRE - Mon Dec 08, 8:00AM CST
Focused on Increasing Awareness and Enhancing Shareholder Value
AmeriCann Partners with Medical Marijuana Applicants in Illinois in $9 Million Alliance
PR Newswire - Mon Oct 20, 5:00AM CDT
AmeriCann, Inc. (ACAN OTCQX), a company that develops cannabis cultivation facilities and provides capital for cannabis entrepreneurs, has partnered with local medical marijuana applicants in the state of Illinois.
AmeriCann, Inc. Commences Trading on the OTCQX Marketplace
PR Newswire - Tue Oct 14, 5:00AM CDT
AmeriCann, Inc. (OTCQX: ACAN), a company that develops cannabis cultivation facilities and provides capital for medical marijuana entrepreneurs, announced that it has been approved for and commenced trading on the OTCQX marketplace, effective October 8, 2014.
